Margulies KB, Hernandez AF, Redfield MM et al (2016) Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical Trial
Patients must understand the risks inherent in GLP-1 therapy, including the effects on anesthesia, the potential for muscle mass loss, the likelihood of weight regain upon discontinuation, and the importance of honest self-reporting
Bachhawat AK, Thakur A, Kaur J, Zulkifli M
While clinical data shows tirzepatide does not increase UTI risk, UTIs can occur coincidentally and need treatment
Clinicians should monitor TSH levels approximately 68 weeks after initiating weight loss injections to ensure thyroid hormone replacement remains adequate
If both are water-based serums, apply whichever is lighter first